Vasorelaxant Mechanism of Herbal Extracts from , , and in the Aorta of Wistar Rats
Authors
Affiliations
(MS) (CC) (TP) and (SV) are used in Morocco to treat hypertension. Our aim was to characterize the composition and vasoreactivity of extracts of MS, CC, TP and SV. The chemical compositions of aqueous extracts of MS, SV and TP, and of a hydromethanolic extract of CC, were identified by HPLC-DAD. The vasoreactive effect was tested in rings of the thoracic aorta of female Wistar rats (8-14 weeks-old) pre-contracted with 10 µM noradrenaline, in the absence or presence of L-NAME 100 µM, indomethacin 10 µM or atropine 6 µM, to inhibit nitric oxide synthase, cyclooxygenase or muscarinic receptors, respectively. L-NAME and atropine decreased the vasorelaxant effect caused by low concentrations of MS. Atropine and indomethacin decreased the vasorelaxant effect of low concentrations of SV. High concentrations of MS or SV and the effect of SV and TP were not altered by any antagonist. The activation of muscarinic receptors and NO or the cyclooxygenase pathway underlie the vasorelaxant effect of MS and SV, respectively. Neither of those mechanisms underlines the vasorelaxant effect of CC and TP. These vasorelaxant effect might support the use of herbal teas from these plants as anti-hypertensives in folk medicine.
Guerguer F, Bouribab A, Karim E, Khedraoui M, Amegrissi F, Raouf Y PLoS One. 2025; 20(1):e0313411.
PMID: 39820594 PMC: 11737685. DOI: 10.1371/journal.pone.0313411.
Exploring Moroccan Medicinal Plants for Anticancer Therapy Development Through In Silico Studies.
Bouribab A, Karim E, Khedraoui M, Abchir O, Errougui A, Raouf Y Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598438 PMC: 11597486. DOI: 10.3390/ph17111528.
Zhao H, Sun R, Wu L, Huang P, Liu W, Ma Q Biochem Genet. 2024; .
PMID: 38806973 DOI: 10.1007/s10528-024-10828-z.
from Jordan: Phytochemical Profiling, Antioxidant, and Antimicrobial Activity Evaluation.
Barhoumi L, Shakya A, Al-Fawares O, Al-Jaber H Molecules. 2024; 29(10).
PMID: 38792265 PMC: 11123705. DOI: 10.3390/molecules29102403.
Lahlou R, Carvalho F, Pereira M, Lopes J, Silva L Pharmaceutics. 2024; 16(4).
PMID: 38675115 PMC: 11054966. DOI: 10.3390/pharmaceutics16040454.